Biote (BTMD) Cost of Revenue (2021 - 2026)

Biote's Cost of Revenue history runs 6 years deep, the most recent figure standing at $14.0 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 10.88% year-over-year to $14.0 million; the TTM figure through Mar 2026 stood at $56.2 million (down 1.85% YoY), while the FY2025 annual figure was $54.9 million, down 5.63% from the prior year.
• Cost of Revenue for Q1 2026 stood at $14.0 million, down from $14.8 million in the prior quarter.
• The five-year high for Cost of Revenue was $15.8 million in Q2 2023, with the low at $12.3 million in Q1 2022.
• The 5-year median for Cost of Revenue is $14.0 million (2026), against an average of $14.1 million.
• The sharpest annual moves came in 2022 and 2025: Cost of Revenue surged 2817.46% in 2022, then retreated 11.39% in 2025.
• Biote's Cost of Revenue stood at $15.4 million in 2022, then declined by 9.2% to $14.0 million in 2023, then climbed by 0.24% to $14.0 million in 2024, then climbed by 5.67% to $14.8 million in 2025, then slipped by 5.75% to $14.0 million in 2026.
• Business Quant data shows BTMD's Cost of Revenue at $14.0 million in Q1 2026, $14.8 million in Q4 2025, and $13.5 million in Q3 2025.